A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis
Greenberg, Richard N, Hurley, Maria Yadira, Hurley, Yadira, Dinh, Dinh V, Mraz, Serena, Vera, Javier Gomez, von Bredow, Dorothea, von Krempelhuber, Alfred, Roesch, Siegfried, Virgin, Garth, Arndtz-Wiedemann, Nathaly, Meyer, Thomas Peter, Schmidt, Darja, Nichols, Richard, Young, Philip, Chaplin, Paul
Published in PloS one (06.10.2015)
Published in PloS one (06.10.2015)
Get full text
Journal Article
Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial
Overton, Edgar Turner, Stapleton, Jack, Frank, Ian, Hassler, Shawn, Goepfert, Paul A., Barker, David, Wagner, Eva, von Krempelhuber, Alfred, Virgin, Garth, Meyer, Thomas Peter, Müller, Jutta, Bädeker, Nicole, Grünert, Robert, Young, Philip, Rösch, Siegfried, Maclennan, Jane, Arndtz-Wiedemann, Nathaly, Chaplin, Paul
Published in Open forum infectious diseases (01.04.2015)
Published in Open forum infectious diseases (01.04.2015)
Get full text
Journal Article
Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis
Greenberg, Richard N, Hurley, Maria Yadira, Dinh, Dinh V, Mraz, Serena, Vera, Javier Gomez, von Bredow, Dorothea, von Krempelhuber, Alfred, Roesch, Siegfried, Virgin, Garth, Arndtz-Wiedemann, Nathaly, Meyer, Thomas Peter, Schmidt, Darja, Nichols, Richard, Young, Philip, Chaplin, Paul
Published in PloS one (10.11.2015)
Published in PloS one (10.11.2015)
Get full text
Journal Article